Equitable Access to COVID-19 Vaccines

NACompletedINTERVENTIONAL
Enrollment

1,722

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 10, 2021

Study Completion Date

June 10, 2021

Conditions
Covid19
Interventions
BEHAVIORAL

SMS delivery of information

Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. Links to information or phone for scheduling will be provided. Messages mimic the clinic's usual practice of information delivery to patients

BEHAVIORAL

Personalized text message delivery of information

Patients are informed via SMS that COVID-19 vaccine doses are available and advised to schedule an appointment. The SMS message is personalized as a recommendation from the primary care clinician

BEHAVIORAL

Interactive or 2-way SMS delivery of information

This intervention is same as in the Arm 2 using personalized messaging from the PCP. In addition, patients are given interactive or 2-way SMS options to obtain additional information about COVID vaccine and answers to frequently asked questions.

Trial Locations (1)

85259

Mayo Clinic, Scottsdale

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Adelante Healthcare

UNKNOWN

lead

Mayo Clinic

OTHER

NCT04952376 - Equitable Access to COVID-19 Vaccines | Biotech Hunter | Biotech Hunter